Abrocitinib may improve itch and quality of life in patients with itch‐dominant atopic dermatitis by Jonathan I. Silverberg, Jacob P. Thyssen, Irina Lazariciu, Daniela E. Myers, Erman Güler, Raj Chovatiya

Connect to this object online.

Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis by Joseph Fowler, Jeffrey Sugarman, Lawrence Sher, Chuanbo Zang, John L. Werth, Daniela E. Myers, Daniela Graham, Alexander Agyei Marfo, Liza Takiya

Connect to this object online.

Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE by Melinda J. Gooderham, MSc, MD, FRCPC, Chia-Yu Chu, MD, PhD, Ricardo Rojo, MD, Hernan Valdez, MD, Pinaki Biswas, PhD, Michael C. Cameron, MD, Claire Feeney, MD, PhD, Gerardo A. Encinas, MD, MHS, Kathleen Peeples-Lamirande, PharmD, MPH, Joseph C. Cappelleri, PhD, Daniela E. Myers, MPH, Marco DiBonaventura, PhD

Connect to this object online.